249 related articles for article (PubMed ID: 17900049)
1. [First and second generation antipsychotics and morphological and neurochemical brain changes in schizophrenia. Review of magnetic resonance imaging and proton spectroscopy findings].
Szulc A
Psychiatr Pol; 2007; 41(3):329-38. PubMed ID: 17900049
[TBL] [Abstract][Full Text] [Related]
2. N-acetylaspartate (NAA) levels in selected areas of the brain in patients with chronic schizophrenia treated with typical and atypical neuroleptics: a proton magnetic resonance spectroscopy (1H MRS) study.
Szulc A; Galińska B; Tarasów E; Kubas B; Dzienis W; Konarzewska B; Poplawska R; Tomczak AA; Czernikiewicz A; Walecki J
Med Sci Monit; 2007 May; 13 Suppl 1():17-22. PubMed ID: 17507880
[TBL] [Abstract][Full Text] [Related]
3. Effects of antipsychotics on brain structure.
Scherk H; Falkai P
Curr Opin Psychiatry; 2006 Mar; 19(2):145-50. PubMed ID: 16612194
[TBL] [Abstract][Full Text] [Related]
4. Proton magnetic resonance spectroscopy study of brain metabolite changes after antipsychotic treatment.
Szulc A; Galinska B; Tarasow E; Waszkiewicz N; Konarzewska B; Poplawska R; Bibulowicz D; Simonienko K; Walecki J
Pharmacopsychiatry; 2011 Jun; 44(4):148-57. PubMed ID: 21710405
[TBL] [Abstract][Full Text] [Related]
5. The effects of antipsychotic treatment on cerebral structure and function in schizophrenia.
Vita A; De Peri L
Int Rev Psychiatry; 2007 Aug; 19(4):429-36. PubMed ID: 17671875
[TBL] [Abstract][Full Text] [Related]
6. The effect of clozapine on neuroimaging findings in schizophrenia.
Ertugrul A; Uluğ B
Psychiatr Danub; 2007 Dec; 19(4):367-9. PubMed ID: 18000491
[TBL] [Abstract][Full Text] [Related]
7. Brain volume changes after withdrawal of atypical antipsychotics in patients with first-episode schizophrenia.
Boonstra G; van Haren NE; Schnack HG; Cahn W; Burger H; Boersma M; de Kroon B; Grobbee DE; Hulshoff Pol HE; Kahn RS
J Clin Psychopharmacol; 2011 Apr; 31(2):146-53. PubMed ID: 21346618
[TBL] [Abstract][Full Text] [Related]
8. Favorable effect on neuronal viability in the anterior cingulate gyrus due to long-term treatment with atypical antipsychotics: an MRSI study.
Braus DF; Ende G; Weber-Fahr W; Demirakca T; Henn FA
Pharmacopsychiatry; 2001 Nov; 34(6):251-3. PubMed ID: 11778146
[TBL] [Abstract][Full Text] [Related]
9. Interaction of hippocampal volume and N-acetylaspartate concentration deficits in schizophrenia: a combined MRI and 1H-MRS study.
Klär AA; Ballmaier M; Leopold K; Häke I; Schaefer M; Brühl R; Schubert F; Gallinat J
Neuroimage; 2010 Oct; 53(1):51-7. PubMed ID: 20541020
[TBL] [Abstract][Full Text] [Related]
10. [Psychopathology of schizophrenia and brain imaging].
Gross G; Huber G
Fortschr Neurol Psychiatr; 2008 May; 76 Suppl 1():S49-56. PubMed ID: 18461545
[TBL] [Abstract][Full Text] [Related]
11. Basal ganglia volumes in drug-naive first-episode schizophrenia patients before and after short-term treatment with either a typical or an atypical antipsychotic drug.
Glenthoj A; Glenthoj BY; Mackeprang T; Pagsberg AK; Hemmingsen RP; Jernigan TL; Baaré WF
Psychiatry Res; 2007 Apr; 154(3):199-208. PubMed ID: 17360162
[TBL] [Abstract][Full Text] [Related]
12. Proton magnetic resonance spectroscopy during initial treatment with antipsychotic medication in schizophrenia.
Bustillo JR; Rowland LM; Jung R; Brooks WM; Qualls C; Hammond R; Hart B; Lauriello J
Neuropsychopharmacology; 2008 Sep; 33(10):2456-66. PubMed ID: 18094668
[TBL] [Abstract][Full Text] [Related]
13. [Clozapine: neuropsychological and neuroimaging studies].
Pérez-Gómez M; Junqué C
Actas Esp Psiquiatr; 1999; 27(5):341-6. PubMed ID: 10545667
[TBL] [Abstract][Full Text] [Related]
14. The effects of antipsychotics on brain structure: what have we learnt from structural imaging of schizophrenia?
Borgwardt SJ; Smieskova R; Fusar-Poli P; Bendfeldt K; Riecher-Rössler A
Psychol Med; 2009 Nov; 39(11):1781-2. PubMed ID: 19476691
[No Abstract] [Full Text] [Related]
15. Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AESOP study.
Dazzan P; Morgan KD; Orr K; Hutchinson G; Chitnis X; Suckling J; Fearon P; McGuire PK; Mallett RM; Jones PB; Leff J; Murray RM
Neuropsychopharmacology; 2005 Apr; 30(4):765-74. PubMed ID: 15702141
[TBL] [Abstract][Full Text] [Related]
16. Neuropsychologic functioning and structural MRI of the brain in patients with schizophrenia.
Premkumar P; Sharma T
Expert Rev Neurother; 2005 Jan; 5(1):85-94. PubMed ID: 15853478
[TBL] [Abstract][Full Text] [Related]
17. Cerebral morphometry and clozapine treatment in schizophrenia.
Bilder RM; Wu H; Chakos MH; Bogerts B; Pollack S; Aronowitz J; Ashtari M; Degreef G; Kane JM; Lieberman JA
J Clin Psychiatry; 1994 Sep; 55 Suppl B():53-6. PubMed ID: 7961574
[TBL] [Abstract][Full Text] [Related]
18. Change in basal ganglia volume over 2 years in patients with schizophrenia: typical versus atypical neuroleptics.
Corson PW; Nopoulos P; Miller DD; Arndt S; Andreasen NC
Am J Psychiatry; 1999 Aug; 156(8):1200-4. PubMed ID: 10450260
[TBL] [Abstract][Full Text] [Related]
19. GABA concentration in schizophrenia patients and the effects of antipsychotic medication: a proton magnetic resonance spectroscopy study.
Tayoshi S; Nakataki M; Sumitani S; Taniguchi K; Shibuya-Tayoshi S; Numata S; Iga J; Ueno S; Harada M; Ohmori T
Schizophr Res; 2010 Mar; 117(1):83-91. PubMed ID: 20022731
[TBL] [Abstract][Full Text] [Related]
20. [Changes in brain structure caused by neuroleptic medication].
Scherk H; Falkai P
Nervenarzt; 2004 Nov; 75(11):1112-7. PubMed ID: 15365632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
